Among the surveyed women, 62 percent underwent lumpectomy to remove their tumors, 16 percent had unilateral mastectomy (8 percent with reconstruction), and 23 percent had bilateral mastectomy (19 percent with reconstruction). With a double mastectomy and reconstruction, women were also three times more likely to stop working altogether. Developed by researchers, including those from University of Manchester in the United Kingdom, the test looks at 18 genetic variants, in the blood or saliva, known to affect the chances of getting breast cancer.
Researchers have found that the composition of healthy female breast tissue bacteria is different from women with breast cancer.
Approximately 252,710 new cases of breast cancer are expected to be diagnosed in 2017, according to the American Cancer Society, with 81 percent being diagnosed in women aged 50 and older. On these grounds, researchers have been looking forward to promoting the usage of this test among women to raise the awareness levels regarding the prospects of developing breast cancer. Adding, "The new test will give women more options and help them to make a more informed decision".More news: Harbaugh: "You Can Criticize" Play-Calling In Loss To Michigan State
More news: West Ham goalkeeper Joe Hart: I will keep pushing myself to limit
More news: Aussie Nobel Peace Prize winners chuffed
Although the rate of breast cancer diagnoses are rising in Europe, a higher proportion of women are surviving the form of cancer - but returning to everyday aspects of life prove challenging; with many survivors unable to return to work, due to a lack of support and consideration by employers. Another limitation of the study is that researchers lacked data on why women missed work, and it's possible some of that time wasn't related to the type of treatment they received.
The information was used alongside other factors to predict an "overall risk estimate" for each of the women. All treatments are individualized for what that particular patient needs.
Too often, discussions women have with their doctors about the best treatment options don't include a conversation about the employment impact, said Dr. Benjamin Smith, of the University of Texas MD Anderson Cancer Center in Houston.